Anxiety can become unexpectedly intense during perimenopause and menopause. Someone who previously handled stress without much difficulty may suddenly experience racing thoughts, physical tension, irritability, heart pounding, difficulty sleeping, or a persistent sense that something is wrong. These symptoms can occur alongside hot flashes, night sweats, disrupted sleep, fatigue, and changing menstrual patterns, creating a feedback loop in which one menopause symptom aggravates another. As cannabis has become more accessible, an increasing number of midlife women report using marijuana or CBD specifically for sleep, mood, and anxiety.
That does not mean marijuana has been established as a treatment for menopause anxiety. Research specifically testing cannabis in perimenopausal and postmenopausal women remains surprisingly limited. Surveys suggest that many users perceive benefits, while broader cannabinoid studies show a much more complicated picture: CBD may reduce certain forms of experimentally induced anxiety under some conditions, whereas THC can either feel calming or provoke anxiety and panic depending on the dose and the individual. Understanding whether marijuana might help menopause anxiety therefore requires separating self-reported relief from controlled clinical evidence and, just as importantly, distinguishing THC from CBD.
Why Anxiety Can Increase During Menopause
The menopause transition involves fluctuating and eventually declining ovarian hormone production, particularly estrogen and progesterone. These hormones interact with neurotransmitter systems involved in mood, stress response, temperature regulation, and sleep. Hormonal changes occur at the same time many women experience disruptive vasomotor symptoms such as hot flashes and night sweats. The American College of Obstetricians and Gynecologists notes that hormonal shifts during the menopause transition can influence brain chemistry and contribute to anxiety, while repeated sleep disruption can make it considerably harder to regulate stress the following day.
The Study of Women’s Health Across the Nation provides some of the strongest long-term evidence. Researchers followed 2,956 women over approximately a decade and found that women who started the study with low anxiety were significantly more likely to develop high anxiety during early perimenopause, late perimenopause, and postmenopause than when they were premenopausal. After adjustment for health problems, stressful life events, vasomotor symptoms, and other factors, the odds remained roughly 56 to 61 percent higher across several menopausal stages. Frequent hot flashes and related vasomotor symptoms were themselves strongly associated with anxiety. These results help explain why treating menopause anxiety may require addressing sleep and hot flashes in addition to the anxiety itself.
Why Women Are Turning to Cannabis
Cannabis use for menopause symptoms is no longer unusual. Researchers from Harvard Medical School and McLean Hospital surveyed 258 perimenopausal and postmenopausal participants and found that 86.1 percent reported current cannabis use within this highly selected sample. Nearly 79 percent said they used cannabis for menopause-related symptoms. Sleep disturbance was the most frequently reported reason, cited by 67.4 percent, while 46.1 percent reported using cannabis for mood or anxiety. Perimenopausal respondents also reported greater anxiety and overall menopause symptom burden than postmenopausal participants.
Those numbers demonstrate interest rather than efficacy. Participants were recruited through online channels, most were already cannabis users, and the study did not randomly assign women to cannabis or placebo. People who believe cannabis helps are naturally more likely to participate in a cannabis survey. A later national survey from the same McLean/Harvard research program found that greater menopause symptom burden was associated with using cannabis medically rather than purely recreationally, reinforcing that symptomatic women are actively turning to cannabis for relief. What the surveys cannot determine is whether marijuana actually caused the improvement users perceived.
What Research Specifically Says About Cannabis and Menopause
A University of Toronto and Mount Sinai Hospital systematic review provides an important reality check. Researchers searched nine major scientific databases for studies evaluating cannabis use for menopause symptoms, including mood, anxiety, sleep problems, and hot flashes. Out of 564 records, only three studies met their inclusion criteria. One involved just 10 postmenopausal women, another examined hot flashes and insomnia in women living with HIV, and a third assessed what menopausal cannabis users expected marijuana to do rather than objectively measuring whether it worked. The authors concluded that cannabis was being used to relieve menopause symptoms despite a striking lack of evidence establishing benefit.
That evidence gap is especially important for anxiety. There has not yet been a large randomized controlled trial assigning women with clinically significant menopause-related anxiety to THC, CBD, a standardized cannabis preparation, and placebo over several months. Consequently, claims that marijuana is a proven treatment for menopause anxiety go beyond current science. At the same time, the absence of menopause-specific trials does not mean cannabinoids have no effect on anxiety. Research in other populations provides useful clues—but those findings need to be interpreted according to the cannabinoid involved.
THC Can Calm Anxiety—or Make It Worse
THC is responsible for most of marijuana’s intoxicating effects and interacts primarily with CB1 receptors throughout the brain. Some people experience relaxation, emotional distance from stressful thoughts, or temporary relief from rumination after using THC. However, the relationship between THC and anxiety is strongly dose- and person-dependent. Reviews of cannabinoid research describe a biphasic pattern in which relatively small exposures may feel calming while larger doses become anxiogenic, producing nervousness, panic, paranoia, or uncomfortable physical sensations.
Research specifically involving adult women illustrates this problem. In a University of Chicago laboratory study, occasional female cannabis users received placebo or oral THC doses of 7.5 and 15 milligrams. THC increased heart rate and anxiety ratings in a dose-dependent manner. That is particularly relevant during menopause because palpitations, sweating, dizziness, and sudden sensations of heat can already accompany anxiety or hot flashes. THC-induced tachycardia may therefore be interpreted as an anxiety attack and intensify rather than relieve the experience.
A large 2026 systematic review and dose-response meta-analysis of 41 randomized placebo-controlled THC experiments involving 1,020 participants reached a similar conclusion. Compared with placebo, THC significantly increased feelings of anxiety and tiredness and reduced alertness. These findings do not mean every THC user becomes anxious—real-world responses vary substantially—but they undermine the idea that marijuana is inherently an anti-anxiety substance. For someone whose menopause symptoms already include panic, rapid heartbeat, or sensitivity to bodily sensations, high-THC products may be especially unpredictable.
CBD May Have a Different Anxiety Profile
CBD does not generally produce the intoxicating high associated with THC and has attracted significant attention as a potential anxiety treatment. The National Center for Complementary and Integrative Health notes that limited human research suggests cannabinoids—particularly CBD—may reduce anxiety under some circumstances. One frequently cited experiment involving 24 people with social anxiety disorder found that CBD reduced anxiety during a simulated public-speaking test compared with placebo. However, NCCIH emphasizes that research remains early and insufficient to establish cannabis or CBD as a broadly effective treatment for anxiety disorders.
Other controlled studies have been less encouraging. A randomized trial involving university students with moderate to severe test anxiety compared placebo with single CBD doses of 150, 300, or 600 milligrams and found no significant reduction in either test anxiety or general anxiety. More recently, a 2025 randomized trial involving 180 stressed students found that one month of low-dose CBD oil did not outperform placebo for anxiety, sleep quality, or overall well-being. These mixed results indicate that CBD’s reputation as a universal natural anxiolytic is ahead of the evidence.
CBD can also change the effects of THC when the two are consumed together. A Johns Hopkins University study partially funded by NCCIH found that participants who ate a brownie containing both 20 milligrams of THC and a large dose of CBD experienced stronger drug effects, greater anxiety, more sedation, worse cognitive and psychomotor performance, and higher heart rates than when they consumed the same THC dose without CBD. CBD slowed THC metabolism after oral consumption, increasing THC exposure. A product advertised as “balanced THC and CBD” therefore should not automatically be assumed to produce less anxiety than THC alone, particularly when taken as an edible.
Sleep, Hot Flashes, and the Anxiety Connection
For some menopausal women, perceived anxiety relief from cannabis may occur indirectly through sleep. Night sweats and hot flashes can repeatedly interrupt sleep, leaving the nervous system more reactive to stress the next day. If a THC-containing product makes someone fall asleep more easily, that person may understandably report less anxiety. The Harvard/McLean menopause survey supports this possibility: sleep disturbance was the most commonly reported menopause symptom for which participants used cannabis, even more commonly than mood or anxiety.
The problem is that evidence supporting cannabinoids as long-term sleep treatments is also weak. NCCIH reports that reviews of cannabinoid therapies for sleep disorders have found insufficient evidence to establish effectiveness, with many studies involving small samples or substantial risk of bias. Regular THC use can also produce tolerance, meaning the same dose becomes less effective over time, and stopping frequent use can temporarily worsen sleep, vivid dreaming, irritability, or anxiety. Cannabis might therefore help someone fall asleep on individual nights without necessarily addressing the underlying reason menopausal sleep is disrupted.
Hot flashes create a similar uncertainty. They are strongly connected with anxiety during the menopausal transition, yet there is little evidence showing that marijuana reliably reduces vasomotor symptoms themselves. The University of Toronto systematic review found essentially no strong clinical evidence for cannabis as a hot-flash therapy, and Harvard experts reviewing the menopause survey noted that participants reported less improvement in hot flashes than in sleep or mood. For women whose anxiety repeatedly follows night sweats or severe vasomotor symptoms, treating those symptoms directly may therefore produce more reliable anxiety improvement than trying to suppress the resulting distress with cannabis.
Potential Risks During Midlife
High-dose THC can cause anxiety, panic, paranoia, impaired short-term memory, dizziness, and rapid heart rate. These reactions may be more disruptive during midlife because other conditions and medications become more common with age. Someone taking antidepressants, blood-pressure medication, sleep aids, anticoagulants, or other prescription drugs may also have cannabinoid interactions to consider. CBD is particularly relevant to drug metabolism because it can inhibit multiple liver enzymes. NCCIH warns that CBD may interact with prescription medications and can also cause sleepiness, gastrointestinal effects, changes in mood, and liver abnormalities in some circumstances.
Regular cannabis use can also lead to cannabis use disorder in a subset of users. Anxiety may create an especially strong reinforcement cycle: a person feels anxious, uses THC for rapid relief, begins relying on it nightly, develops tolerance, increases the dose, and later experiences greater anxiety or insomnia when attempting to stop. A 2024 critical review found that cannabis use and cannabis use disorder were statistically associated with anxiety, while evidence most strongly supported self-medication as one explanation for the relationship. In other words, anxious people frequently use marijuana because they feel it helps, but that pattern does not necessarily mean cannabis is treating the underlying anxiety disorder.
Smoking deserves separate consideration. Marijuana smoke exposes the lungs to combustion products, while THC can acutely increase heart rate. Edibles avoid smoke but have delayed onset and longer-lasting effects, increasing the risk of accidentally consuming too much. Products also vary widely in cannabinoid content, and NCCIH warns that commercially available CBD products may contain more or less CBD—or unexpected THC—than indicated on their labels. These differences make it difficult to translate research using standardized THC or CBD doses into predictions about individual dispensary products.
Where Cannabis Fits Among Menopause Anxiety Treatments
Cannabis is not FDA-approved for menopause anxiety, and no major menopause organization currently considers marijuana a first-line treatment for menopausal anxiety. ACOG advises women experiencing persistent or worsening anxiety during perimenopause or menopause to discuss it with their obstetrician-gynecologist because symptoms may represent an anxiety disorder that can be treated. Depending on the situation, evidence-based approaches can include psychotherapy, antidepressant medications, treatment of sleep disturbances, lifestyle interventions, and management of menopause symptoms contributing to anxiety. Hormone therapy may also be appropriate for selected women whose broader menopausal symptoms warrant it, although it is not prescribed simply as a universal anxiety treatment.
This does not mean every woman who finds cannabis useful must dismiss her experience. Survey research clearly indicates that many women perceive meaningful improvement in sleep and anxiety, and cannabis may provide short-term relaxation for some individuals. The important distinction is between individual symptom relief and a treatment supported by robust clinical trials. Someone considering cannabis for menopause anxiety has more reason to pay attention to THC dose, CBD content, route of administration, medication interactions, history of panic attacks, cardiovascular symptoms, and frequency of use than to strain names or marketing labels such as “indica” and “sativa.”
Final Thoughts on Marijuana for Menopause Anxiety
The best current evidence supports a cautious middle ground. Anxiety genuinely can intensify during the menopausal transition. The long-running SWAN study demonstrated increased odds of high anxiety during perimenopause and postmenopause among women who had not previously experienced substantial anxiety, while vasomotor symptoms were strongly associated with anxiety severity. At the same time, Harvard/McLean surveys show that large numbers of cannabis-using midlife women report turning to marijuana for sleep, mood, and anxiety relief. These findings demonstrate a real clinical need and a real pattern of cannabis use—but they do not yet prove effectiveness.
THC and CBD also should not be treated as interchangeable. THC may temporarily feel calming at lower exposures yet reliably increases anxiety in some controlled experiments, particularly as the dose rises. CBD has shown potential anxiolytic effects in selected laboratory studies but has failed to outperform placebo in others, and high oral CBD doses can sometimes intensify THC exposure when the cannabinoids are consumed together. Until well-designed randomized trials specifically study medicinal cannabis for menopause-related anxiety, marijuana is best viewed as an emerging, incompletely understood option rather than an established menopause treatment. Women with significant or new anxiety should consider the broader menopause picture—including hot flashes, sleep disruption, medications, cardiovascular symptoms, and mental health history—rather than assuming that cannabis alone addresses the underlying cause.
